Blog - Page 3 of 5717 - QualityStocks

WednesdayAug 19, 2026 11:22 am

QualityStocksNewsBreaks – American Fusion Inc. (OTC: AMFN) Receives FINRA Clearance for Form 211, Advances OTCQB Application

American Fusion (OTC: AMFN), developer of the proprietary Texatron(TM) Fusion Engine(TM), announced that the Financial Industry Regulatory Authority (“FINRA”) has cleared the Form 211 filed on its behalf by Alpine Securities Corporation pursuant to Rule 15c2-11 under the Securities Exchange Act of 1934. The clearance permits Alpine, as the company’s sponsoring market maker, to initiate proprietary priced quotations in AMFN common stock and resolves the final open item previously identified in American Fusion’s OTCQB Venture Market application process. The company believes it is now in the final stages of that process and intends to work with Alpine and OTC Markets Group to complete the remaining administrative steps, with OTCQB qualification still…

WednesdayAug 19, 2026 10:55 am

QualityStocksNewsBreaks – InvestorNewsBreaks – Earth Science Tech, Inc. (OTC: ETST) Acquires Zoolzy to Expand Pharmaceutical Supply Chain and Veterinary Market Reach

Earth Science Tech (OTC: ETST), a strategic holding company focused on a diversified portfolio, announced the acquisition of Zoolzy LLC, a Doral, Florida-based wholesale distributor of active pharmaceutical ingredients (“APIs”) and finished FDA-approved prescription products. Operating from a 3,684-square-foot facility, Zoolzy is expected to integrate into ETST’s supply chain and enable its compounding pharmacies to procure APIs at competitive wholesale pricing, which the company says could increase overall profit margins. The acquisition also broadens ETST’s access to novel APIs for custom compounding and provides immediate procurement access to common veterinary medications. ETST plans to leverage the new supply line to…

WednesdayAug 19, 2026 10:45 am

QualityStocksNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Advances Deployment-Focused Robotics Strategy as AI Moves Deeper Into Physical Operations

Nightfood Holdings (OTCQB: NGTF), operating as TechForce Robotics, is positioning its AI-enhanced robotics, industrial automation and Robotics-as-a-Service (“RaaS”) strategy around real-world deployments as global robotics adoption accelerates. International Federation of Robotics (“IFR”) data cited in a recent editorial shows global industrial robot installations totaled 542,000 units in 2024, while RaaS fleets expanded 31%. TechForce recently executed a letter of intent with NBR Intelligence Pte. Ltd. for a factory automation initiative beginning with five pilot systems and contemplating a phased rollout toward a nonbinding planning target of approximately 5,000 systems, subject to assessments, pilot acceptance, site identification, financing and definitive agreements.…

WednesdayAug 19, 2026 10:30 am

Earth Science Tech Inc. (ETST) Continues Steady Growth with Acquisition of California-Based Compounding Pharmacy

Earth Science Tech, an expanding health-based holding company, recently announced the acquisition of Meduvo LLC, a compounding pharmacy that currently operates from a 2,000-square-foot facility in La Verne, California The acquisition grows the company’s network to 34 jurisdictions in the United States and establishes a strategic West Coast operational hub In addition to Meduvo, ETST also operates other compounding pharmacies through its specialized subsidiaries RxCompoundStore.com LLC (“RxCS”) and Mister Meds LLC Earth Science Tech (OTC: ETST), a strategic holding company in the healthcare, pharmacy, and telemedicine sector, recently acquired Meduvo LLC, a compounding pharmacy. Meduvo currently operates from a 2,000-square-foot…

WednesdayAug 19, 2026 10:30 am

QualityStocksNewsBreaks – HWAL, Inc. (OTCID: HWAL) Engages IBN for Corporate Communications Strategy

HWAL, Inc. (OTCID: HWAL), a diversified entertainment and intellectual property company, has engaged IBN, a multifaceted financial news and publishing company serving private and public entities, to assist with its corporate communications strategy. HWAL’s operations are anchored by a collection of music and media assets assembled over several decades, and through subsidiary Melody Trust and Lunar Records, a joint venture between Melody Trust and Space Blue, the company is pursuing licensing, artist development and new forms of digital and immersive entertainment while using blockchain-enabled models to manage and monetize intellectual property. Recent initiatives have expanded HWAL’s music holdings and introduced…

WednesdayAug 19, 2026 9:45 am

American Fusion(TM) Inc. (AMFN) Appoints Strategic Advisor as the Company Expands Scientific and IP Platform

American Fusion has added Texas Tech physicist Dr. Noah D’Amico as a Strategic Advisor. D’Amico’s work includes nuclear diagnostics, neutron detection, radiation measurement, vacuum systems and AI-assisted particle-track analysis. The company has also filed six additional U.S. patent applications, bringing its total U.S. applications to 82. American Fusion(TM) has begun testing its Texatron(TM) platform at Texas Tech University after completing initial laboratory preparations and verifying its remote ignition system. The next testing phase is expected to examine subsystems including plasma and magnetic-field control, ignition, fuel delivery and electronic components. American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies,…

WednesdayAug 19, 2026 9:00 am

Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Myelin-Protecting MS Therapy as Treatment Paradigm Evolves

MS drug development is increasingly expanding beyond controlling inflammation toward approaches designed to protect the nervous system and address mechanisms underlying progressive disability. Remyelination and protection of existing myelin remain major unmet needs in MS, as no approved therapy has established the ability to restore previously damaged myelin. Quantum BioPharma’s Lucid-MS is a patented new chemical entity designed to inhibit demyelination and protect myelin without suppressing the immune system. The U.S. FDA has cleared Quantum BioPharma to proceed with its planned phase 2 clinical trial of Lucid-MS in people with multiple sclerosis. Multiple sclerosis (“MS”) treatment has traditionally focused on…

TuesdayAug 18, 2026 3:32 pm

QualityStocksNewsBreaks – Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Steps Up Cameron REE Exploration with 2026 Field Program

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising. Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF) has commenced its 2026 exploration program at its 100%-owned Cameron Rare Earth Element (“REE”) Project in British Columbia, building on encouraging findings from previous exploration campaigns. The three-week program will combine geological mapping and prospecting with rock, soil and stream sediment sampling, ground radiometric surveys and integrated data analysis to refine REE target corridors, identify potential bedrock sources and prioritize areas for future trenching and first-pass drilling. Earlier Phase 1 and 2 exploration identified enrichment of both light and heavy rare earth elements…

TuesdayAug 18, 2026 2:39 pm

QualityStocksNewsBreaks – MindWave Innovations Inc. (NYSE American: APUS) Puts Institutional Infrastructure at the Center of Its Digital Strategy

MindWave Innovations (NYSE American: APUS) is positioning its proprietary MindChain as institutional-grade blockchain infrastructure designed to support the next phase of digital asset adoption. The insured Layer 2 network is intended to address institutional priorities such as security, compliance, scalability and efficient settlement while supporting applications including Bitcoin treasury management, decentralized finance and real-world asset tokenization. MindChain also serves as the foundation for MindWaveDAO, which combines board-controlled Bitcoin treasury strategies with segregated custody and an AI-powered yield engine designed to optimize returns while managing risk. The company’s strategy is beginning to move toward implementation, including a financing arrangement of up to…

TuesdayAug 18, 2026 1:50 pm

QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Marks Key IP Milestone for GelrinC Manufacturing

Regentis Biomaterials (NYSE American: RGNT) is strengthening the manufacturing and intellectual property foundation behind its GelrinC cartilage-repair technology as it moves toward broader commercialization. The company recently received a Japanese Notice of Allowance for patent protection covering the organic solvent-free manufacturing process and ready-to-use liquid formulation behind GelrinC. This followed a recent U.S. issuance that expanded its global IP portfolio to nearly 30 patents. Regentis’ proprietary manufacturing process increases yield fivefold, simplifies production and is built to support commercial-scale manufacturing—important advantages for an off-the-shelf cartilage-repair product designed to avoid the complexity and cost of cell-based procedures. The milestone comes as the company…

Site Search

Company Search